Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients

Lignende værker

• Development and validation of a hypoxia-related gene signature to predict overall survival in early-stage lung adenocarcinoma patients
  af: Sun, Jing, et al.
  Udgivet: (2020)
• Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer
  af: Run Shi, et al.
  Udgivet: (2020-05-01)
• Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer
  af: Shi, Run, et al.
  Udgivet: (2020)
• Mast cell‐based molecular subtypes and signature associated with clinical outcome in early‐stage lung adenocarcinoma
  af: Bao, Xuanwen, et al.
  Udgivet: (2020)
• Immune landscape and a novel immunotherapy-related gene signature associated with clinical outcome in early-stage lung adenocarcinoma
  af: Bao, Xuanwen, et al.
  Udgivet: (2020)